Literature DB >> 21167800

Using X-chromosomal markers in relationship testing: calculation of likelihood ratios taking both linkage and linkage disequilibrium into account.

Andreas O Tillmar1, Thore Egeland, Bertil Lindblom, Gunilla Holmlund, Petter Mostad.   

Abstract

X-chromosomal markers in forensic genetics have become more widely used during recent years, particularly for relationship testing. Linkage and linkage disequilibrium (LD) must typically be accounted for when using close X-chromosomal markers. Thus, when producing the weight-of-evidence, given by a DNA-analysis with markers that are linked, the normally used product rule is invalid. Here we present an implementation of an efficient model for calculating likelihood ratios (LRs) with markers on the X-chromosome which are linked and in LD. Furthermore, the model was applied on several cases based on data from the eight X-chromosomal loci included in the Mentype(®) Argus X-8 (Biotype). Using a simulation approach we showed that the use of X-chromosome data can offer valuable information for choosing between the alternatives in each of the cases we studied, and that the LR can be high in several cases. We demonstrated that when linkage and LD were disregarded, as opposed to taken into account, the difference in calculated LRs could be considerable. When these differences were large, the estimated haplotype frequencies often had a strong impact and we present a method to estimate haplotype frequencies. Our conclusion is that linkage and LD should be accounted for when using the tested set of markers, and the used model is an efficient way of doing so.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 21167800     DOI: 10.1016/j.fsigen.2010.11.004

Source DB:  PubMed          Journal:  Forensic Sci Int Genet        ISSN: 1872-4973            Impact factor:   4.882


  9 in total

1.  Development and population study of the 12 X-STR loci multiplexes PCR systems.

Authors:  Qiu-Ling Liu; Hu Zhao; Jian-Ding Chen; Xiao-Guang Wang; De-Jian Lu; Li Quan
Journal:  Int J Legal Med       Date:  2012-02-16       Impact factor: 2.686

2.  Mixtures with relatives and linked markers.

Authors:  Guro Dørum; Daniel Kling; Andreas Tillmar; Magnus Dehli Vigeland; Thore Egeland
Journal:  Int J Legal Med       Date:  2015-11-27       Impact factor: 2.686

3.  Analysis of 12 X-STRs in Greenlanders, Danes and Somalis using Argus X-12.

Authors:  Carmen Tomas; Vânia Pereira; Niels Morling
Journal:  Int J Legal Med       Date:  2011-09-02       Impact factor: 2.686

4.  A general model for likelihood computations of genetic marker data accounting for linkage, linkage disequilibrium, and mutations.

Authors:  Daniel Kling; Andreas Tillmar; Thore Egeland; Petter Mostad
Journal:  Int J Legal Med       Date:  2014-11-26       Impact factor: 2.686

5.  Curiosities of X chromosomal markers and haplotypes.

Authors:  Daniel Kling
Journal:  Int J Legal Med       Date:  2017-05-26       Impact factor: 2.686

6.  Assigning forensic body fluids to donors in mixed body fluids by targeted RNA/DNA deep sequencing of coding region SNPs.

Authors:  S Ingold; G Dørum; E Hanson; J Ballantyne; C Haas
Journal:  Int J Legal Med       Date:  2020-01-27       Impact factor: 2.686

7.  Allele and haplotype diversity of X-chromosomal STRs in Ivory Coast.

Authors:  Serena Pasino; Stefano Caratti; Massimiliano Del Pero; Alfredo Santovito; Carlo Torre; Carlo Robino
Journal:  Int J Legal Med       Date:  2011-06-30       Impact factor: 2.686

8.  Linkage, recombination and mutation rate analyses of 16 X-chromosomal STR loci in Sri Lankan Sinhalese pedigrees.

Authors:  Nandika Perera; Ruvini Wijithalal; Gayani Galhena; Gaya Ranawaka
Journal:  Int J Legal Med       Date:  2022-01-13       Impact factor: 2.686

9.  Using object oriented bayesian networks to model linkage, linkage disequilibrium and mutations between STR markers.

Authors:  Daniel Kling; Thore Egeland; Petter Mostad
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.